HIC-1 Activators
The realm of HIC-1 activators encompasses a broad spectrum of chemical entities, each playing a distinct role in finely tuning the activity of the HIC-1 protein. As a tumor suppressor, HIC-1 holds significance in orchestrating various cellular processes, and the chemicals identified as activators exert their influence through an intricate interplay of direct and indirect mechanisms. This diversity highlights the intricate regulatory networks that converge on HIC-1 activation. Direct activators, exemplified by Trichostatin A, Vorinostat, and Sodium Butyrate, function by directly inhibiting histone deacetylation. This inhibition leads to the augmentation of acetylation on histones linked to the HIC-1 promoter, creating a molecular environment conducive to the accessibility of transcription factors. Consequently, this process promotes the transcriptional activation of HIC-1, unraveling a direct and fundamental regulatory pathway.
In addition to direct activators, compounds like 5-Azacytidine and 3-Deazaneplanocin A operate through mechanisms that prevent DNA and histone methylation, respectively. By thwarting these epigenetic modifications, these chemicals support unhindered transcription, enabling the activation of HIC-1. These direct activators collectively showcase the diverse molecular strategies employed to directly influence the HIC-1 protein. On the indirect front, agents like Curcumin, Resveratrol, and 2-Deoxyglucose navigate cellular pathways such as Wnt/β-catenin, SIRT1, and glycolysis, respectively. By modulating these pathways, these compounds exert their influence on HIC-1 expression and activity. Whether through the inhibition of repressive signaling or the induction of cellular stress, these indirect activators create an environment conducive to HIC-1 activation, underscoring the multifaceted nature of their impact. In summary, the varied mechanisms orchestrated by HIC-1 activators not only illuminate the complexity of HIC-1 regulation but also offer valuable insights into potential strategies for manipulating its activity across diverse cellular contexts. The understanding of specific pathways influenced by these compounds enhances our grasp of the intricate networks governing HIC-1 activation, paving the way for targeted interventions in conditions where HIC-1 function proves pivotal.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a potent HDAC inhibitor, directly activates HIC-1 by inhibiting histone deacetylation. This leads to increased acetylation of histones associated with the HIC-1 promoter, facilitating its transcriptional activation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, indirectly activates HIC-1 by preventing DNA methylation. This epigenetic modification normally represses HIC-1 expression, so its inhibition allows for unhindered transcription and subsequent activation of HIC-1. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, an HDAC inhibitor, directly activates HIC-1 by preventing histone deacetylation. By maintaining an acetylated state on histones linked to the HIC-1 promoter, vorinostat facilitates the accessibility of transcription factors, promoting the transcriptional activation of HIC-1. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, an HDAC inhibitor, directly activates HIC-1 by inhibiting histone deacetylation. This leads to increased acetylation of histones linked to the HIC-1 promoter, facilitating its transcriptional activation. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, an NAD+ precursor and SIRT inhibitor, indirectly activates HIC-1 by modulating the SIRT1 pathway. Inhibition of SIRT1 by nicotinamide leads to increased acetylation of histones associated with the HIC-1 promoter, promoting its transcriptional activation. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
Scriptaid, an HDAC inhibitor, directly activates HIC-1 by inhibiting histone deacetylation. This results in increased acetylation of histones linked to the HIC-1 promoter, facilitating the accessibility of transcription factors and supporting the transcriptional activation of HIC-1. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 (Entinostat), an HDAC inhibitor, directly activates HIC-1 by preventing histone deacetylation. By maintaining an acetylated state on histones associated with the HIC-1 promoter, entinostat facilitates the accessibility of transcription factors, promoting the transcriptional activation of HIC-1. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxyglucose, a glucose analogue, indirectly activates HIC-1 through the inhibition of glycolysis. This metabolic perturbation induces cellular stress and activates AMP-activated protein kinase (AMPK), which in turn supports HIC-1 activation by phosphorylation-mediated mechanisms. | ||||||
Allyl disulfide | 2179-57-9 | sc-252359 | 25 g | $80.00 | ||
Allyl disulfide, an organosulfur compound, indirectly activates HIC-1 by modulating the NF-κB pathway. It inhibits NF-κB activation, leading to decreased expression of NF-κB-dependent repressors of HIC-1. This relief of repression indirectly supports HIC-1 activation, promoting its transcriptional activity. | ||||||